Archived Insight | January 9, 2020

Segal Shares Insights on Family Business Recruiting

Sal DiFonzo and Myrna Hellerman talk to Chief Executive magazine about how family-run businesses can better recruit talent to their organizations.

Read what they have to say in the interview on Chief Executive.

Read the Interview

Questions about the article?

Get in touch. Our press team will be happy to help.

Non-family members in a family business? Segal talks about how to attract the right kind of talent.

Sal DiFonzo and Myrna Hellerman talk to Chief Executive magazine about the challenges family-run businesses face when it comes to recruiting talent, and offer possible solutions to this unique problem.

Some of the insights shared in the interview include:

How to leverage cash incentives for potential hires
The role of equity grants in attracting non-family executives
Phantom stock units and the part they play in a talent recruitment strategy

Find out more on how family-run businesses can discover and incorporate start talent into their organizations.

Read the Interview

See more from Segal

Asian Female Pharmacist Uses Computer To Check Inventory For A Drug

Designing and Negotiating Affordable Pharmacy Benefits

Learn how health plan sponsors can improve pharmacy benefit value through PBM contracting, formulary management and clinical oversight.

Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Corporate, Pharmaceutical, Healthcare Cost Management

Read Full Insight

Focused Business Woman Working On Laptop Computer Reading

Many Retirement Plans Must Be Amended by December 31, 2026

Learn which retirement plans must be amended by December 31, 2026 and how SECURE Act discretionary and required amendments differ.

Retirement, Compliance, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Corporate

Read Full Insight

Man Self Injecting GLP 1 Weight Loss Medication Pen At Home

GLP-1s Have Disrupted the Market for Other Diabetes Drugs

Segal’s SHAPE data shows how rising GLP-1 use coincided with declines in insulin, Metformin and DPP-4 inhibitor use.

Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Corporate, Pharmaceutical

Read Full Insight

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.